Dow Down 0.18% Nasdaq Up 0.39%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
70.39 Down 0.83(1.17%) Sep 2, 4:00PM EDT
|After Hours : 70.40 Up 0.01 (0.01%) Sep 2, 4:20PM EDT
Prev Close:71.22
Open:71.45
Bid:69.39 x 100
Ask:495.00 x 700
1y Target Est:83.13
Beta:0.64
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:69.18 - 71.45
52wk Range:55.04 - 84.25
Volume:792,051
Avg Vol (3m):1,137,840
Market Cap:10.36B
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 1.17%10.36B
FOLDDown 3.06%548.55M
SHPGDown 0.31%47.62B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.28
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-2.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback